{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:37:30Z","timestamp":1793716650537,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Capital\u2019s Funds for Health Improvement and Research","award":["No.2020-2-4172"],"award-info":[{"award-number":["No.2020-2-4172"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atopic dermatitis (AD) is a chronic relapsing skin disease that has long-term physical and mental health impacts on children with this condition. Current treatments mainly include anti-inflammatory, antibacterial, and anti-allergic interventions, systemic therapy, and recently emerging target-focused agents. However, these treatments have limited effectiveness and unwanted side effects. The use of traditional Chinese medicine (TCM) in the treatment of AD has a long history, with promising efficacies, low toxicity, and improvements in the quality of life of patients with AD. Longmu Tang granule, a TCM, has been used to effectively treat AD since 2008 through doctors\u2019 prescriptions. To scientifically evaluate the clinical efficacy and safety of Longmu Tang granule, we proposed to launch a single-centred, double-blinded, randomised, placebo-controlled trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this single-centred, double-blinded, randomised, placebo-controlled clinical trial conducted at Xiyuan Hospital of China Academy of Chinese Medical Sciences, a total of 60 participants will be randomly assigned (1:1) to receive the Longmu Tang granule or placebo granule for 8 weeks. The primary outcome will be evaluated using the index of Scoring Atopic Dermatitis. The secondary outcomes will be evaluated using the Children\u2019s Dermatology Life Quality Index and the number cancellation test. The mechanistic evidence will be the serum levels of inflammatory cytokines, including immunoglobulin E, tumour necrosis factor-\u03b1, interleukin-1, and interleukin-6.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The results of this trial will provide evidence of the efficacy and safety of the Longmu Tang granule and prove its anti-inflammatory action in patients with AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Chinese Clinical Trial Registry <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/chictr.org\">Chictr.org<\/jats:ext-link> ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.aspx?proj=62586\">ChiCTR2100041591<\/jats:ext-link>. Registered on 1 January 2021<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06313-w","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:03:02Z","timestamp":1652090582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial"],"prefix":"10.1186","volume":"23","author":[{"given":"Ya-qin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao-tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-xi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-yan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yao","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-cheng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-yan","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5837-3641","authenticated-orcid":false,"given":"Na","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-xun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"issue":"10247","key":"6313_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","volume":"396","author":"SM Langan","year":"2020","unstructured":"Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345\u201360.","journal-title":"Lancet."},{"issue":"4","key":"6313_CR2","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jid.2018.10.029","volume":"139","author":"Y Kim","year":"2019","unstructured":"Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA Jr, Gold DR, Thyssen JP, et al. Racial\/ethnic differences in incidence and persistence of childhood atopic dermatitis. J Invest Dermatol. 2019;139(4):827\u201334.","journal-title":"J Invest Dermatol"},{"key":"6313_CR3","doi-asserted-by":"publisher","first-page":"29751","DOI":"10.1038\/srep29751","volume":"6","author":"Y Guo","year":"2016","unstructured":"Guo Y, Li P, Tang J, Han X, Zou X, Xu G, et al. Prevalence of atopic dermatitis in Chinese children aged 1-7\u2009ys. Sci Rep. 2016;6:29751.","journal-title":"Sci Rep"},{"issue":"3","key":"6313_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jaci.2019.01.003","volume":"143","author":"WF Davidson","year":"2019","unstructured":"Davidson WF, Leung DYM, Beck LA, Berin CM, Boguniewicz M, Busse WW, et al. Report from the National Institute of Allergy and Infectious Diseases workshop on \u201cAtopic dermatitis and the atopic march: Mechanisms and interventions\u201d. J Allergy Clin Immunol. 2019;143(3):894\u2013913.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"6313_CR5","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/bjd.14697","volume":"175","author":"MA Strom","year":"2016","unstructured":"Strom MA, Fishbein AB, Paller AS, Silverberg JI. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br J Dermatol. 2016;175(5):920\u20139.","journal-title":"Br J Dermatol"},{"issue":"1","key":"6313_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12887-018-1022-1","volume":"18","author":"H Cao","year":"2018","unstructured":"Cao H, Yan S, Gu C, Wang S, Ni L, Tao H, et al. Prevalence of attention-deficit\/hyperactivity disorder symptoms and their associations with sleep schedules and sleep-related problems among preschoolers in mainland China. BMC Pediatr. 2018;18(1):70.","journal-title":"BMC Pediatr"},{"issue":"2","key":"6313_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.aller.2015.04.006","volume":"44","author":"F Catal","year":"2016","unstructured":"Catal F, Topal E, Soylu N, Ozel Ozcan O, Celiksoy MH, Babayi\u011fit A, et al. Psychiatric disorders and symptoms severity in preschool children with atopic eczema. Allergol Immunopathol (Madr). 2016;44(2):120\u20134.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"1","key":"6313_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2133.2006.07185.x","volume":"155","author":"PE Beattie","year":"2006","unstructured":"Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol. 2006;155(1):145\u201351.","journal-title":"Br J Dermatol"},{"issue":"6","key":"6313_CR9","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2500\/aap.2018.39.4175","volume":"39","author":"B Reed","year":"2018","unstructured":"Reed B, Blaiss MS. The burden of atopic dermatitis. Allergy Asthma Proc. 2018;39(6):406\u201310.","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"6313_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","volume":"138","author":"M Feld","year":"2016","unstructured":"Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, et al. The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol. 2016;138(2):500\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"6313_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000351280","volume":"20","author":"S Li","year":"2013","unstructured":"Li S, Kuchta K, Tamaru N, Lin Y, Iwasaki S, Wang R, et al. Efficacy of a novel herbal multicomponent traditional Chinese medicine therapy approach in patients with atopic dermatitis. Forsch Komplementmed. 2013;20(3):189\u201396.","journal-title":"Forsch Komplementmed"},{"issue":"8810","key":"6313_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0140-6736(92)92424-E","volume":"340","author":"MP Sheehan","year":"1992","unstructured":"Sheehan MP, Rustin MH, Atherton DJ, Buckley C, Harris DW, Brostoff J, et al. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis. Lancet. 1992;340(8810):13\u20137.","journal-title":"Lancet."},{"issue":"13","key":"6313_CR13","first-page":"1839","volume":"36","author":"H Zhang","year":"2011","unstructured":"Zhang H, Zhang L, Liu Y. Studies on chemical components and pharmacological activities of Os Draconis (Longgu) and Ostreae Concha. China J Chinese Mater Med. 2011;36(13):1839\u201340 [article in Chinese].","journal-title":"China J Chinese Mater Med"},{"issue":"11","key":"6313_CR14","first-page":"774","volume":"27","author":"JH Wang","year":"2011","unstructured":"Wang JH, Mao W, Wang XH, et al. Analysis of bacterial colonization in skin lesions and non-skin lesions of patients with Atopic dermatitis. Chin J Leprosy Skin Di. 2011;27(11):774\u20136 [article in Chinese].","journal-title":"Chin J Leprosy Skin Di"},{"key":"6313_CR15","first-page":"3401","volume":"08","author":"B Jiang","year":"2018","unstructured":"Jiang B, Su Y, Cai YH. Experimental study on inhibitory effects and its mechanism of forsythia on Staphylococcus aureus. Genomics Appl Biol. 2018;08:3401\u20136 [article in Chinese].","journal-title":"Genomics Appl Biol"},{"key":"6313_CR16","doi-asserted-by":"publisher","first-page":"3472608","DOI":"10.1155\/2016\/3472608","volume":"2016","author":"MJ Bae","year":"2016","unstructured":"Bae MJ, See HJ, Choi G, Kang CY, Shon DH, Shin HS. Regulatory T cell induced by Poria cocos bark exert therapeutic effects in murine models of atopic dermatitis and food allergy. Mediat Inflamm. 2016;2016:3472608.","journal-title":"Mediat Inflamm"},{"key":"6313_CR17","volume-title":"Clinical observation and mechanism of jian pi zhu yun prescription in the treatment of pediatric atopic dermatitis","author":"XY Tian","year":"2019","unstructured":"Tian XY. Clinical observation and mechanism of jian pi zhu yun prescription in the treatment of pediatric atopic dermatitis. Beijing: Beijing University of Chinese Medicine; 2019 [academic dissertation in Chinese]."},{"issue":"1","key":"6313_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1398-9995.2004.00622.x","volume":"60","author":"N Pucci","year":"2005","unstructured":"Pucci N, Novembre E, Cammarata MG, et al. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index. Allergy. 2005;60(1):113\u20136.","journal-title":"Allergy."},{"issue":"1","key":"6313_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1398-9995.2011.02719.x","volume":"67","author":"ME Schram","year":"2012","unstructured":"Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy. 2012;67(1):99\u2013106.","journal-title":"Allergy."},{"key":"6313_CR20","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","volume":"132","author":"MS Lewis-Jones","year":"1995","unstructured":"Lewis-Jones MS, Finlay AY. The Children\u2019s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. Br J Dermatol. 1995;132:942\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"6313_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s13555-019-00333-2","volume":"9","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, de Bruin-Weller M, Eckert L, et al. Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children\u2019s Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis. Dermatol Ther (Heidelb). 2019;9(4):799\u2013805.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"06","key":"6313_CR22","first-page":"356","volume":"10","author":"N Lang","year":"2011","unstructured":"Lang N, Chi HY, She YY, Zhao YD, Tian FY, Zhang WR, et al. Clinical efficacy evaluation of Longmu Decoction in the treatment of atopic dermatitis. Chin J Dermatovenerol Integr Tradit Western Med. 2011;10(06):356\u20138 [article in Chinese].","journal-title":"Chin J Dermatovenerol Integr Tradit Western Med"},{"issue":"12","key":"6313_CR23","first-page":"1151","volume":"24","author":"YD Zhao","year":"2010","unstructured":"Zhao YD, Yao CH, She YY, Chi HY, Lang N, Li B, et al. Effect of tranquilizing method on clinical symptoms of patients with atopic dermatitis. Chin J Dermatovenereol. 2010;24(12):1151\u20133 [article in Chinese].","journal-title":"Chin J Dermatovenereol"},{"issue":"1","key":"6313_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00910561","volume":"19","author":"N Roth","year":"1991","unstructured":"Roth N, Beyreiss J, Schlenzka K, Beyer H. Coincidence of attention deficit disorder and atopic disorders in children: empirical findings and hypothetical background. J Abnorm Child Psychol. 1991;19(1):1\u201313.","journal-title":"J Abnorm Child Psychol"},{"key":"6313_CR25","doi-asserted-by":"publisher","first-page":"110142","DOI":"10.1016\/j.biopha.2020.110142","volume":"127","author":"F Yan","year":"2020","unstructured":"Yan F, Li F, Liu J, Ye S, Zhang Y, Jia J, et al. The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis. Biomed Pharmacother. 2020;127:110142.","journal-title":"Biomed Pharmacother"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06313-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:04:46Z","timestamp":1652090686000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06313-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6313"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06313-w","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"22 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has been approved by the Ethics Approval Committee of Xiyuan Hospital of China Academy of Chinese Medical Sciences (approval number: 202XLA031-2). Participants of the trial will sign informed consent forms at baseline, and their personal information will remain strictly confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"379"}}